Nattapon Thongkamchoo’s Post

Ready to crack this medication puzzle? Test your knowledge with this pharmacy question! Can you guess why ACE inhibitors are commonly prescribed for hypertension and heart failure? Choose wisely! #rxcourse #pebcexams #pebcexampreparations

New Blog! Renal denervation (RDN) is an emerging therapeutic option for patients with refractory hypertension and even for those not currently on medication. Read here: https://ow.ly/hwcr50Shs9r #NursingBlog #Healthcare

Medication tightrope: Erythropoietin + thiazides – a potential duo with a watchful eye on blood pressure. 📈 Let's discuss, learn, and empower ourselves on this health journey! 💬 ✅Combining erythropoietin, a hormone stimulating red blood cell production, with thiazide diuretics may elevate blood pressure. Erythropoietin can increase red blood cell volume, and thiazides, commonly used as diuretics, may cause fluid retention. This dual effect can lead to hypertension. Monitoring blood pressure is crucial when using these medications concurrently. Healthcare providers should carefully assess the necessity of this combination, considering alternative treatments or adjusting dosages to mitigate the risk of elevated blood pressure. #pharmd #pharmdlife #pharmdstudent #doctorofpharmacy

Globally, as the pace of modern life accelerates and work pressure increases, the number of hypertension patients continues to rise, with nearly 30% of adults affected by this condition. Enalapril Maleate is a widely used antihypertensive drug, proven to effectively control blood pressure with minimal side effects. As an ACE inhibitor, Enalapril works by reducing the level of angiotensin II in the body, causing vasodilation and lowering blood pressure. Its long-term use doesn’t lead to tolerance, making it a reliable option for treating primary and renovascular hypertension, as well as heart failure at all stages. Want to know how Enalapril Maleate works to lower blood pressure? Visit our website to learn more! https://lnkd.in/gDWzy6u8 #TJCY #EnalaprilMaleate #Hypertension #BloodPressure #Chemicals

A new study finds that the migraine preventative drug atogepant significantly reduces the occurrence of rebound headaches, potentially allowing sufferers to rely less on pain medication known to trigger these headaches. https://lnkd.in/giqfprRH #TalentInfluencersLeaderboard #FortreaAlwaysOn #Fortreacareers

#Linagliptin Effective and well-tailored pharmacotherapy in #type2diabetes is crucial for patients well-being. One of the most important treatment options is #Linagliptin, providing flexibility as it can be taken both as monotherapy and in combination with other drugs. #Linagliptin therapy offers multiple benefits, including: - consistent blood sugar control and a reduced risk of hypoglycemia - linagliptin does not affect renal function, making it a safer choice for patients with kidney concerns. - oral form ensures ease of administration, integrating seamlessly into daily routines. #Linagliptin stands out as a patient-friendly therapy, emphasizing comfort and convenience in #diabetescare. Check out our wide diabetes portfolio https://lnkd.in/eS6ZxJYf Contact us: api@polpharma.com

Stop-Loss Carriers – Our solution helps you keep CKD claims under the deductible to reduce costs. Avoid large ESRD claim costs by being proactive and identifying CKD patients on the verge of kidney failure, thus avoiding expensive dialysis costs. Learn more at https://bit.ly/3WDlEL1. #ChronicKidneyDisease #KidneyTransplant #Dialysis

No need to feel the 'pressure' of monitoring your BP anymore! 😷 Check out our Cuffless NIBP solution that can optimize BP measurement by providing a complete and painless evaluation of blood pressure levels and behaviour over long periods. The device can help improve antihypertensive drug treatment compliance and hypertension control rates by seamlessly monitoring BP patterns in individual patients. To know more, visit 👉 : http://bit.ly/3LbW6S4 #Cuffless #BloodPressure #MedicalDevices #EngineeringTheChange

In a trial of nearly 600 patients with hypertension, a four-drug, single-pill combination (that contained small doses of irbesartan, indapamide, amlodipine, and bisoprolol) lowered 24-hour systolic blood pressure more than full-dose irbesartan and led to higher rates of control. The incidence of adverse effects was similar between groups. While promising, clinical experience with using four-drug combination pills is limited and therefore not yet recommended as initial treatment. Explore What's New in #hypertension: https://ow.ly/6zzm50Snm3T #ClinicalUpdates #meded

A step-by-step algorithm for the optimal assessment and management of hypertension among patients on dialysis ca. 2024 #Nephpearls https://lnkd.in/g6W66YpN